← FDA DRUG APPROVALS

FDA ANDA · ANDA062779

CEPHALEXIN

Sponsor: VITARINE

APPLICATION
ANDA062779
TYPE
ANDA
LATEST ACTION
1989-04-24
ROUTE
ORAL
DOSAGE FORM
FOR SUSPENSION
MARKETING STATUS
Discontinued

Products

CEPHALEXINDiscontinued
CEPHALEXIN EQ 125MG BASE/5ML · FOR SUSPENSION · ORAL

Approval history

1989-04-24Manufacturing (CMC) · Supplement 4AP
1989-02-14Manufacturing (CMC) · Supplement 3AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →